tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market

Moleculin Biotech (MBRX) Financial Statements

Compare
1,499 Followers

Moleculin Biotech Financial Overview

Moleculin Biotech's market cap is currently $13.63M. The company's EPS TTM is $-7.122; its P/E ratio is ―; Moleculin Biotech is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -127.00K$ -222.00K$ -260.00K$ -285.00K
Operating Income$ -26.64M$ -29.63M$ -30.64M$ -22.97M$ -19.74M
EBITDA$ -26.52M$ -29.50M$ -30.51M$ -22.80M$ -19.54M
Net Income$ -21.76M$ -29.77M$ -27.41M$ -8.86M$ -15.00M
Balance Sheet
Cash & Short-Term Investments$ 4.28M$ 23.55M$ 43.15M$ 70.90M$ 15.17M
Total Assets$ 16.93M$ 38.22M$ 57.42M$ 84.09M$ 29.03M
Total Debt$ 478.00K$ 574.00K$ 451.00K$ 159.00K$ 277.00K
Net Debt$ -3.80M$ -22.98M$ -42.69M$ -70.74M$ -14.90M
Total Liabilities$ 10.95M$ 12.14M$ 5.23M$ 5.10M$ 11.27M
Stockholders' Equity$ 5.98M$ 26.07M$ 52.19M$ 78.99M$ 17.76M
Cash Flow
Free Cash Flow$ -23.88M$ -24.23M$ -27.71M$ -18.97M$ -18.15M
Operating Cash Flow$ -23.86M$ -24.10M$ -27.64M$ -18.95M$ -17.77M
Investing Cash Flow$ -13.00K$ -124.00K$ -67.00K$ -19.00K$ -374.00K
Financing Cash Flow$ 4.63M$ 4.65M$ -23.00K$ 74.72M$ 22.55M
Currency in USD

Moleculin Biotech Earnings and Revenue History

Moleculin Biotech Debt to Assets

Moleculin Biotech Cash Flow

Moleculin Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis